The ability for Tf to act as the natural ligand for ferroportin-mediated iron export, while also being able to deliver iron through the TfR mechanism, made this protein an attractive candidate for a PD therapeutic where iron is elevated in a discrete nucleus (SN pars compacta22). The gene discussed is TF; the disease is Parkinson disease.